Advertisement

Topics

Latest "Lyne Laboratories" News Stories

21:06 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "Lyne Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about Lyne Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Lyne Laboratories for you to read. Along with our medical data and news we also list Lyne Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of Lyne Laboratories Companies for you to search.

Showing "Lyne Laboratories" News Articles 1–25 of 2,000+

Relevant

Lyne Fortin to Leave Theratechnologies by Year-End

MONTREAL, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced that it was informed by Lyne Fortin, Senior Vice President and Chief Commercial Officer, that she will retire from the Company by year-end. Until then, she will remain in her position and will help in the transition of her files to her successor. “I want to take this opportunity...


Reviewing IDEXX Laboratories (IDXX) & The Competition

IDEXX Laboratories is one of 25 publicly-traded companies in the "Diagnostic substances" industry, but how does it contrast to its rivals? We will compare IDEXX Laboratories to related businesses based on the strength of its dividends, analyst recommendations, institutional ownership, earnings, profitability, valuation and risk. IDEXX Laboratories has higher revenue and earnings than its rivals.

Bionik Laboratories Issues Letter to Stockholders

I joined Bionik Laboratories as CEO in September 2017, having served as a director of the Company for the previous two months.  A focus Read more...


Dr. Reddy's Laboratories Regains Worldwide Rights To DFA-02

NEW DELHI (dpa-AFX) - Dr. Reddy's Laboratories Ltd. (RDY), along with its subsidiaries, announced the termination of the license granted to Armis Biopharma, Inc. for its investigational antibacter...

Dr. Reddy's Laboratories Launches Hervycta In India

NewsDr. Reddy’s Laboratories has launched Hervycta, a biosimilar of Roche’s Herceptin, in India, indicated for the treatment of HER2-positive cancers (early breast cancer, metastatic breast cancer, and metastatic gastric cancer).

Credit-Märkte 25.9.: Abbott Laboratories, Vodafone, Commerzbank, Bertelsmann ...

Gestern preiste Abbott Laboratories eine Dreifach-Tranche (A: EUR 1,14 Mrd., 2J, MS+25 BP; B: EUR 1,14 Mrd., 5J, MS+50 BP; C: EUR 1,14 Mrd., 8J, MS+75 BP). Ein Blick auf die Orderbücher zeigt, dass...

Chemistry, Spectroscopy Software Features Stereochemical Recognition

Product AnnouncementBio-Rad Laboratories, Inc. announced the release of its KnowItAll software and spectral databases.Contributed Author: 

Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech

Dr. Reddy’s Laboratories has signed a distribution agreement with UCB to supply the latter’s epilepsy drug Briviact in India. As...Read More... The post Deals this week: Dr. Reddy’s Laboratories, Pluristem Therapeutics, Fortress Biotech appeared first on Pharmaceutical Technology.

ACM acquires ABS to accelerate growth driven by clinical trials, toxicology

ACM Global Laboratories has acquired ABS Laboratories to better serve its clients in the clinical trial market with an expanded "scientific acumen," says company president.

FDA Approves First Generic Version Of Suboxone

NewsDr. Reddy's Laboratories announces final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. market.

Discovery Laboratories, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 20062018] Prices from USD $175

Discovery Laboratories, Inc. Strategy, SWOT and Corporate Finance ReportSummaryDiscovery Laboratories, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsWindtree Thera...

Scapa Seals Debt Funding Facility Of Up To £60m

Technical tapes and bonding solutions specialist Scapa Group has boosted its war chest for growth with a new debt funding facility.The international group headquartered in Ashton-Under-Lyne has secured a committed £40m facility with further access to an additional uncommitted £20m "accordion" facility.The four-and-half-year revolving credit facility has been provided by a three ban...

IDEXX Laboratories Inc Q2 Earnings Rise

WASHINGTON (dpa-AFX) - IDEXX Laboratories Inc (IDXX) released earnings for its second quarter that advanced from last year.The company's profit came in at $108.68 million, or $1.23 per share. This...

Riding bacterium to the bank

(DOE/Sandia National Laboratories) Jet fuel, pantyhose and plastic soda bottles: all three could be made from bioengineered bacteria, as Sandia National Laboratories has now demonstrated.

Morepen Laboratories net jumps by 94% in Q1

Morepen Laboratories has posted impressive financial performance during the first quarter ended June 2018 and its consolidated net profit went up by 93.7 per cent to Rs. 2.46 crore from Rs. 1.27 crore

CloudLIMS? New Client Portal Enhances Customer Service Capabilities of Biobanks and Testing Laboratories

New portal is designed for biorepositories and testing laboratories

Diesel doesn't float this boat

(DOE/Sandia National Laboratories) Marine research could soon be possible without the risk of polluting either the air or the ocean. It's thanks to a new ship design and feasibility study led by Sandia National Laboratories.

Dr. Reddy’s Laboratories sells antibiotic manufacturing site in Bristol, Tennessee

Under the terms of the agreement, Dr. Reddy’s sold all the issued and outstanding membership interests in Dr. Reddy’s Laboratories Tennessee, LLC and certain related assets. Dr. Reddy’s The post Dr. Reddy’s Laboratories sells antibiotic manufacturing site in Bristol, Tennessee appeared first on Pharma Business review.

Dr. Reddy's Laboratories announces its intent to appeal court decision in preliminary ...

Dr. Reddy’s Laboratories Ltd.INVESTOR RELATIONSSAUNAK SAVLA, +91-40-49002135saunaks@drreddys.comorMEDIA RELATIONSCALVIN PRINTER, +91-40-49002121calvinprinter@drreddys.com Read more...

Zacks: Analysts Expect Impax Laboratories Inc (IPXL) Will Announce Quarterly Sales of $184.90 Million

Equities analysts expect Impax Laboratories Inc to announce sales of $184.90 million for the current fiscal quarter, according to Zacks . Four analysts have made estimates for Impax Laboratories' earnings.

Wickham Laboratories to present at Cleanroom Technology Conference 2018

Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16 May at 2:30PM, at the National Conference Centre in Birmingham... The post

Dr Reddy's Laboratories net jumps to Rs. 456 crore in Q1

Dr Reddy's Laboratories, a Rs. 14,200 crore plus fifth largest Indian phrma major, has posted growth in net profit during the first quarter ended June 2018 on account of launch of new product in US and emerging markets.

IDEXX Laboratories, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

IDEXX Laboratories, Inc. Strategy, SWOT and Corporate Finance ReportSummaryIDEXX Laboratories, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsIDEXX Laboratories IDE...

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

"Soon-to-be discarded patient samples create an opportunity for laboratories to generate recurring revenue, while iSpecimen's network of laboratories helps researchers gain access to precisely the Read more...

Technical Perspectives on Drug Makers Stocks -- Impax Labs, Merck, Novartis, and Pfizer

Impax Laboratories Shares in Hayward, Californiaheadquartered Impax Laboratories Inc. rose slightly by 0.78%, ending Wednesday's trading session at $19.45. The stock recorded a Read more...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks